Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis.
about
Aberrant splicing and drug resistance in AMLIdentification of a secondary promoter of CASP8 and its related transcription factor PURαA short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly.Alternatively spliced caspase-6B isoform inhibits the activation of caspase-6A.New basal cell carcinoma susceptibility loci.Alternative RNA splicing and cancerAlternative splicing and its impact as a cancer diagnostic marker.Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus.Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.The enigmatic roles of caspases in tumor developmentCaspases and cancer.Harnessing the cell death pathway for targeted cancer treatment.Harnessing of Programmed Necrosis for Fighting against Cancers.Hematopoietic stem/progenitor cells are less prone to undergo apoptosis than lymphocytes despite similar DNA damage response.Regulation of cell death in cancer-possible implications for immunotherapy.MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.Evasion of apoptosis as a cellular stress response in cancer.CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.Physiological and Pathological Function of Serine/Arginine-Rich Splicing Factor 4 and Related Diseases.The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
P2860
Q28076011-4A637C54-8D2C-4CBA-A01B-3D21BB761966Q33836484-24A73C40-4DAD-48C5-BDF5-F62300B0E29FQ34117158-C8B58C18-92FE-46E4-83A9-FACEE122308BQ34186347-1FCFE9A5-836F-4727-92CC-30BCFB25DAC5Q35487317-E878245D-F36E-46E4-B9FB-CE69A9B4A669Q35589667-DEF1C0D1-E0A3-4DF4-907B-7CD8BD0B6194Q36345822-6CA1A297-C94F-43DE-B783-C6B3D0F0C980Q36392411-D2FFC8E9-0A78-4E03-82C3-6A4B7D0605DBQ36967364-34F1D0D9-B175-4B64-A85C-45315A99E5F9Q37304724-8049A89C-46FF-4E23-B63D-3B758E58AFF8Q37342739-A01722FA-AFD1-4E73-8477-C40007042193Q37860139-52F8CD3A-5C23-4756-941A-2AA5F989F429Q37942090-B8971D40-7D0F-4F54-9CBC-A4D5F77AF30AQ38227878-10F94C39-EBC2-4877-A1C1-47E8F98A6EC8Q38834086-E27A5EE8-3E78-4F35-ADC7-DBE2341EFA39Q39461469-36FAE953-B71E-4F23-8D04-F0E6E000678EQ40102576-03942C29-7ADA-42E8-B95C-C0A0DD83BF14Q40307186-18D4E63E-F21A-4393-8646-CD5622709A2EQ41788901-2405C640-3430-42F5-BEA2-0E6C84CAC33AQ46288123-73069137-FEE6-40BA-BC08-0300C0B4C049Q55082864-4584C726-D30B-4E84-8C1C-27D4031B23B0Q58758774-B791E75D-1BA3-4307-BE14-4056E6E7B27E
P2860
Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@en
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@nl
type
label
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@en
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@nl
prefLabel
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@en
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Caspase-8L expression protects ...... from CD95-mediated apoptosis.
@en
P2093
Chirlei Büneker
Christian Beltinger
Gergely Jarmy
Hubert Schrezenmeier
Karsten Stahnke
Markus Wiesneth
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208432
P407
P577
2005-03-01T00:00:00Z
P5875
P6179
1023053545